Redcon1
Double Tap
Serving
1 Capsule(s)
Per container
30
Form
capsule-unknown
UPC
810044571578
DSLD
Formula hash
7ed5abf96019
Catalog
114
products
With avoid flag
4
products
FDA recalls
0
history
CAERS
6
reports
Caution-flaggedObjective label signals
Flagged excipients
1
0 avoid · 1 caution
FDA recalls
0
no recall history
CAERS reports
2
FDA consumer events
Certifications
0
none recorded
1 excipient carry authority-caution citations. · Every flag below links to the authority's published citation.
NIH LiverTox
1 ingredient with hepatotoxicity classification
Worst severity: Category B
- Green TeaCategory B
LiverTox Category B (for concentrated extracts only, not brewed tea). High-dose EGCG (>800 mg/day) from supplements linked to hepatotoxicity. EFSA 2018 opinion. USP verification recommended.
LiverTox →
Supplement Facts
6 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Acetyl L-Carnitine herbUNII · S3Z3R3X6RL | 1000 mcg | — |
| Green Tea (Camellia sinensis) leaf extract Green TeaherbUNII · W2ZU1RY8B0 LiverTox B | 500 mg | — |
| Caffeine herbUNII · 3G6A5W338E | 150 mg | — |
| Dicaffeine Malate Caffeineherb | 150 mg | — |
| 1,3,7,9-Tetramethyluric Acid TBDherbUNII · EJ939L81MY | 100 mg | — |
| Cocoabuterol cocoaherb | 100 mg | — |
Flagged excipients
1 flagged · authority citations
- ◐ CAUTIONFD&C Red #40color
EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).
FDA CAERS · adverse event context
2
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Gelatin · Dicalcium Phosphate · Magnesium Stearate · Silica